Paloma Partners’s SkinHealth Systems SKIN Stock Holding History

Paloma Partners’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,291	Closed	-$436K	–	1688
2022 Q1	$436K	Buy	+1,291	New	+$426K	0.01%	866
2021 Q4	–	Sell	-1,416	Closed	-$735K	–	2084
2021 Q3	$735K	Buy	+1,416	New	+$623K	0.02%	430

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Paloma Partners's SKIN Position: Q2 2022 in Review

Paloma Partners sold out of SkinHealth Systems (SKIN) in Q2 2022, closing a stake of 1,291 shares — an estimated $436K sold.

Paloma Partners first reported a position in SKIN in Q3 2021 and held it in 2 quarters. The position peaked at $735K in Q3 2021. 161 funds tracked by Wall St. Rank hold SKIN as of Q2 2022.

Paloma Partners reported no remaining SkinHealth Systems position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 1,291 SkinHealth Systems shares in Q2 2022, an estimated $436K.
Paloma Partners first reported a position in SkinHealth Systems in Q3 2021 and held it in 2 quarters.
Paloma Partners's SkinHealth Systems position peaked at $735K in Q3 2021.
161 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.